At least 240 000 individuals experience a transient ischemic attack each year in the United
States. Transient ischemic attack is a strong predictor of subsequent stroke. The 90-day …

OBJECTIVE Management of stroke due to large vessel occlusion (LVO) has undergone
unprecedented change in the past decade. Effective treatment with thrombectomy has …

Importance Dual antiplatelet therapy (DAPT) with clopidogrel and aspirin is effective in
preventing recurrent strokes after minor ischemic stroke or transient ischemic attack (TIA) …

Cardiovascular (CV) events in patients with cancer can be caused by concomitant CV risk
factors, cancer itself, and anticancer therapy. Since malignancy can dysregulate the …

Platelets are important cellular targets in cardiovascular disease. Based on insights from
basic science, translational approaches and clinical studies, a distinguished anti-platelet …

This narrative review provides an overview of the posterior circulation and the clinical
features of common posterior circulation stroke (PCS) syndromes in the posterior arterial …

Importance In the Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT)
trial, acute treatment with clopidogrel-aspirin was associated with significantly reduced risk …

BACKGROUND: Stroke mortality and related functional disability have been declining over
the last two decades, but stroke continues to represent the second leading cause of …

Background and purpose Current pieces of evidence support the short-term use of dual
antiplatelet (DAPT) in minor ischemic stroke or transient ischemic attack (TIA) based on the …

Background Antiplatelet agents are central in the management of vascular disease. The use
of dual antiplatelet therapy (DAPT) for the management of thromboembolic complications …